Forty patients with compensated chronic active hepatitis B and elevated aminotransferases who were HBsAg and HBeAg positive were randomised to a treatment group receiving recombinant interferon alpha-2b (rIFN alpha-2b) or no treatment as a control group. The treated patients were divided into 2 groups, group I (n = 12) received IFN in a dose of 5 MU/m2 thrice weekly by subcutaneous injection for 16 weeks, and group II (n = 8) received the same dose daily for the same duration. Patients were followed up for 12 months after therapy ended. Initiation of IFN therapy was associated with an increase in aminotransferases, reaching a peak at 4-6 weeks in most patients, associated with clearance of HBeAg. At end of follow-up, 81% of the treated patients had cleared HBeAg vs 33% of the control group (p less than 0.01). Changes in other HBV markers were more frequent in the treated patients, though insignificantly. The type of response to therapy was significantly related to the duration of illness, being shortest in those who cleared HBsAg. A complete response to therapy with loss of HBsAg was associated with marked reduction in biochemical and histological activity. A partial response with clearance of HBeAg was associated with moderate improvement in biochemical parameters and ongoing activity in liver histology; whereas persistence of HBeAg was associated with elevated aminotransferases and histological deterioration in most cases. The rise in aminotransferases during seroconversion was associated with hepatic decompensation and death on 3 occasions: one during spontaneous seroconversion, and the other 2 during IFN therapy.(ABSTRACT TRUNCATED AT 250 WORDS)
Membrane selective electrodes were used to determine Naftidrofuryl Oxalate (NFL) in presence of its alkaline degradate (I). The membrane selective electrodes include construction of water insoluble ion-association complexes. These are NFL-tetraphenyl borate (NFL-TPB), NFL-reinikate (NFL-R). These complexes are used as electroactive materials, in poly-vinyl chloride (PVC) matrix membrane sensors, for the determination of NFL. The performance characteristics of these sensors, evaluated according to IUPAC recommendations, reveal fast, stable and linear response for NFL. The sensors are used for determination of NFL in plasma. The suggested method was used to determine NFL in synthetic mixtures and in commercial tablets. The obtained results were statistically compared with official HPLC method, showing no significant difference with respect to accuracy and precision.
Poly(acrylamide)‐starch graft copolymer was treated independently with sodium hydroxide and different acid solutions. The different acids include phosphoric, hydrochloric and sulphuric acid. The treatment was carried out under a variety of conditions including sodium hydroxide concentration, time and duration of hydrolysis as well as type of acid used. The extent of hydrolysis was assessed by estimating amide and carboxyl content as well as the acrylate and starch content before and after treatment. It was found that the increment in carboxyl content is equal to the decrement in amide on using sodium hydroxide concentration up to 1n, while using higher concentrations than 1n lead to differences in formed carboxyl and decreased amide groups. The magnitude of this difference depends on sodium hydroxide concentration as well as temperature and duration of hydrolysis. The maximum value of carboxyl content obtained was 593 m‐eq/100g sample. The acidic treatment of the starch copolymer does not affect the conversion of amide groups to carboxyl groups and the lonely effect was hydrolysis of starch component of the copolymer. Evaluation of the alkali teated copolymer as cation exchanger was carried out. The absorption efficiency % of different cations depends on the associated anions and follow the order: Cu2+ > Zn2+ > Co2+ Mg2+.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.